VIS832, a Novel CD138-targeting Monoclonal Antibody, Potently Induces Killing of Human Multiple Myeloma and Further Synergizes with IMiDs or Bortezomib in Vitro and in Vivo

Tengteng Yu,Bharat Chaganty,Liang Lin,Lijie Xing,Boopathy Ramakrishnan,Kenneth Wen,Phillip A. Hsieh,Andrew Wollacott,Karthik Viswanathan,Hedy Adari,Shih-Feng Cho,Yuyin Li,Hailin Chen,Wenjuan Yang,Yan Xu,Gang An,Lugui Qiu,Nikhil Munshi,Gregory Babcock,Zachary Shriver,James R. Myette,Kenneth C. Anderson,Yu-Tzu Tai

Blood cancer journal（2020）

引用 26|浏览76
暂无评分
关键词
Cancer,Targeted therapies,Biomedicine,general,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要